1: Zumoff B, Monder C, Bradlow HL. Studies in the biotransformation of cortisol to the cortoic acids in man. II. The central role of tetrahydrocortisol and tetrahydrocortisone as intermediates. J Clin Endocrinol Metab. 1977 Apr;44(4):647-50. PubMed PMID: 849978.
2: Meklat N, Tabet JC, de Ceaurriz J. Urine ratio of tetrahydrocortisol to tetrahydrodeoxycortisol to screen for the systemic administration of cortisone and hydrocortisone. Forensic Sci Int. 2009 Mar 10;185(1-3):e13-7. doi: 10.1016/j.forsciint.2008.12.011. Epub 2009 Jan 29. PubMed PMID: 19185436.
3: Panin LE, Kunitsyn VG, Poliakov LM. [Mechanisms of interaction of tetrahydrocortisol and its complex with apolipoprotein A-I and DNA regulatory cis-elements of CC(GCC)5/GG(CGG)5 type]. Biofizika. 2008 Jan-Feb;53(1):42-7. Russian. PubMed PMID: 18488499.
4: Panin LE, Knyazev RA, Sumenkova DV, Polyakov LM. Effect of complexes of apolipoprotein A-I with tetrahydrocortisol and pregnenolone on protein biosynthesis in rat hepatocytes culture. Bull Exp Biol Med. 2007 Sep;144(3):291-3. PubMed PMID: 18457017.
5: Yamashita K, Nakagawa R, Okuyama M, Honma S, Takahashi M, Numazawa M. Simultaneous determination of tetrahydrocortisol, allotetrahydrocortisol and tetrahydrocortisone in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry. Steroids. 2008 Aug;73(7):727-37. doi: 10.1016/j.steroids.2008.02.009. Epub 2008 Feb 26. PubMed PMID: 18394666.
6: Panin LE, Tuzikov FV, Tuzikova NA, Pliakov LM. [Features of interaction of complexes cortisol-apolipoprotein A-I and tetrahydrocortisol-apolipoprotein A-I with eukariotic DNA]. Mol Biol (Mosk). 2006 Mar-Apr;40(2):300-9. Russian. PubMed PMID: 16637271.
7: Turpeinen U, Markkanen H, Sane T, Hämäläinen E. Determination of free tetrahydrocortisol and tetrahydrocortisone ratio in urine by liquid chromatography-tandem mass spectrometry. Scand J Clin Lab Invest. 2006;66(2):147-59. PubMed PMID: 16537248.
8: Raffaelli A, Saba A, Vignali E, Marcocci C, Salvadori P. Direct determination of the ratio of tetrahydrocortisol+allo-tetrahydrocortisol to tetrahydrocortisone in urine by LC-MS-MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jan 18;830(2):278-85. Epub 2005 Nov 23. PubMed PMID: 16310418.
9: Panin LE, Tuzikov FV, Gimautdinova OI. Tetrahydrocortisol-apolipoprotein A-I complex specifically interacts with eukaryotic DNA and GCC elements of genes. J Steroid Biochem Mol Biol. 2003 Dec;87(4-5):309-18. PubMed PMID: 14698212.
10: Stiefel P, García-Morillo JS, Jimenez L, Pamies E, Miranda ML, Carneado J, Villar J, Leal-Cerro A. Role of ketoconazole treatment in urinary-free cortisol-to-cortisone and tetrahydrocortisol-to-tetrahydrocortisone ratios in nonectopic Cushing's syndrome. Endocrine. 2002 Aug;18(3):279-84. PubMed PMID: 12450320.
11: Panin LE, Gimautdinova OI, Kuznetsov PA, Akimzhanova MV, Tuzikov FV. Effect of tetrahydrocortisol-apolipoprotein A-I complex on the secondary structure of eukaryotic DNA and its interaction with RNA-polymerase. Biochemistry (Mosc). 2002 Jul;67(7):790-4. PubMed PMID: 12139478.
12: Panin LE, Tuzikov FV, Tuzikova NA, Gimautdinova OI, Poliakov LM. [Interaction of tetrahydrocortisol-apolipoprotein A-I complex with eukaryotic DNA and with single-stranded oligonucleotides]. Mol Biol (Mosk). 2002 Jan-Feb;36(1):96-102. Russian. PubMed PMID: 11862720.
13: Panin LE, Tuzikov FV, Tuzikova NA, Usynin IF, Gimautdinova OI. [Effect of tetrahydrocortisol-apolipoprotein A-I complex on RNA polymerase interaction with eukaryotic DNA and the rate of protein biosynthesis in hepatocytes]. Bioorg Khim. 2001 Mar-Apr;27(2):114-9. Russian. PubMed PMID: 11357395.
14: Furuta T, Namekawa T, Shibasaki H, Kasuya Y. Synthesis of deuterium-labeled tetrahydrocortisol and tetrahydrocortisone for study of cortisol metabolism in humans. Steroids. 1999 Dec;64(12):805-11. PubMed PMID: 10576214.
15: Furuta T, Namekawa T, Shibasaki H, Kasuya Y. Simultaneous determination of tetrahydrocortisol and tetrahydrocortisone in human plasma and urine by stable isotope dilution mass spectrometry. J Chromatogr B Biomed Sci Appl. 1998 Mar 20;706(2):181-90. PubMed PMID: 9551804.
16: Clark AF, Lane D, Wilson K, Miggans ST, McCartney MD. Inhibition of dexamethasone-induced cytoskeletal changes in cultured human trabecular meshwork cells by tetrahydrocortisol. Invest Ophthalmol Vis Sci. 1996 Apr;37(5):805-13. PubMed PMID: 8603865.
17: Southren AL, Wandel T, Gordon GG, Weinstein BI. Treatment of glaucoma with 3 alpha, 5 beta-tetrahydrocortisol: a new therapeutic modality. J Ocul Pharmacol. 1994 Spring;10(1):385-91. PubMed PMID: 8207341.
18: Teicher BA, Sotomayor EA, Huang ZD, Ara G, Holden S, Khandekar V, Chen YN. beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma. Cancer Chemother Pharmacol. 1993;33(3):229-38. PubMed PMID: 8269604.
19: Southren AL, l'Hommedieu D, Gordon GG, Weinstein BI. Intraocular hypotensive effect of a topically applied cortisol metabolite: 3 alpha, 5 beta-tetrahydrocortisol. Invest Ophthalmol Vis Sci. 1987 May;28(5):901-3. PubMed PMID: 3570698.
20: Aranoff G, Rösler A. Urinary tetrahydrocortisone and tetrahydrocortisol glucosiduronates in normal newborns, children and adults. Acta Endocrinol (Copenh). 1980 Jul;94(3):371-5. PubMed PMID: 7424479.